Published in J Urol on June 01, 2005
Adverse effects of drug therapies on male and female sexual function. World J Urol (2006) 0.80
Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.75
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci (2009) 2.32
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol (2005) 2.17
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol (2006) 2.15
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer (2005) 2.15
Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev (2009) 2.14
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun (2004) 1.90
Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol (2005) 1.88
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun (2006) 1.75
Propolis, an old remedy used in modern medicine. Fitoterapia (2002) 1.71
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol (2007) 1.67
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology (2003) 1.60
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol (2009) 1.55
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) (2008) 1.51
Milk thistle in liver diseases: past, present, future. Phytother Res (2010) 1.51
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. Eur Urol (2007) 1.46
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer. Eur Urol (2004) 1.43
Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma. Urology (2013) 1.42
Antibacterial activity of Cuminum cyminum L. and Carum carvi L. essential oils. J Agric Food Chem (2005) 1.42
Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology (2002) 1.41
Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-Binding: requirement for establishing chronic persistent infection. PLoS Pathog (2009) 1.37
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets. Mol Cell Endocrinol (2008) 1.30
Antibacterial activity of Coriandrum sativum L. and Foeniculum vulgare Miller Var. vulgare (Miller) essential oils. J Agric Food Chem (2004) 1.27
Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells (2005) 1.27
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun (2005) 1.26
The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther (2006) 1.21
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem (2004) 1.20
Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun (2004) 1.18
Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin Investig Drugs (2003) 1.13
Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. BMC Cancer (2006) 1.13
Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology (2005) 1.12
Novel insights into the pharmacology of flavonoids. Phytother Res (2013) 1.11
Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res (2007) 1.11
Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab (2009) 1.10
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med (Berl) (2007) 1.07
The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J (2002) 1.06
The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol (2004) 1.06
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology (2005) 1.06
Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine (2005) 1.06
Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer. BJU Int (2011) 1.05
Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population. Infect Immun (2005) 1.05
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy. Prostate (2012) 1.03
Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection. Am J Obstet Gynecol (2002) 1.02
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors. J Med Chem (2007) 1.02
Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell Microbiol (2008) 1.01
Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J (2009) 1.01
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med (Berl) (2009) 1.01
Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol (2004) 1.01
Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine (2012) 1.00
Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation. Br J Pharmacol (2006) 1.00
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl) (2012) 1.00
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med (Berl) (2005) 0.99
PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. J Biol Chem (2010) 0.98
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol (2007) 0.98
Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene (2003) 0.97
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem Pharmacol (2013) 0.96
Coccygeal movement: assessment with dynamic MRI. Eur J Radiol (2007) 0.96
Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother Res (2003) 0.95
Warfarin interactions with medicinal herbs. Nat Prod Commun (2014) 0.94
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol (2012) 0.93
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol (2011) 0.93
Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med (Berl) (2008) 0.92
Structure-activity relationships for saponins from Allium hirtifolium and Allium elburzense and their antispasmodic activity. Planta Med (2005) 0.91
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer (2009) 0.91
BAT3 regulates Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis of macrophages. PLoS One (2012) 0.91
Antispasmodic saponins from bulbs of red onion, Allium cepa L. var. Tropea. J Agric Food Chem (2005) 0.91
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. Urol Int (2010) 0.89
The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J Biol Chem (2002) 0.89
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. Clin Chim Acta (2012) 0.89
Inhibitory effect of ginger (Zingiber officinale) on rat ileal motility in vitro. Life Sci (2004) 0.89
Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. Histopathology (2009) 0.89
Garlic: empiricism or science? Nat Prod Commun (2009) 0.89
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. Biochem Pharmacol (2006) 0.89
Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. Int J Surg Pathol (2009) 0.88
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer (2005) 0.88
Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. Life Sci (2003) 0.88
HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol (2012) 0.88
The pharmacology of TRP channels. Br J Pharmacol (2014) 0.87
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol (2014) 0.86
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients. Cancer Chemother Pharmacol (2011) 0.86
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. Oncol Rep (2010) 0.86
Spasmolytic effects of nonprenylated rotenoid constituents of Boerhaavia diffusa roots. J Nat Prod (2006) 0.86
Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study. Medicine (Baltimore) (2015) 0.85